New serum-derived albumin scaffold seeded with adipose-derived stem cells and olfactory ensheathing cells used to treat spinal cord injured rats

Histology and Histopathology

Volumn 28, Issue 1, 2013, Pages 89-100

  Ferrero Gutierrez, Amaia ^a   Menendez Menendez, Yolanda ^a   Alvarez Viejo, Maria ^a   Meana, Alvaro ^b   Otero, Jesus ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Centro Comunitario de Sangre y Tejidos Del Principado de Asturias (CCST)   (Spain)

Author keywords

Adipose derived stem cells (ADSCs); Albumin scaffold; Cell transplantation; Olfactory ensheathing cells (OECs); Spinal cord injury

Indexed keywords

ALBUMINOID; TISSUE SCAFFOLD;

ADIPOCYTE; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CHEMISTRY; CONVALESCENCE; CYTOLOGY; GLIA; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; NERVE REGENERATION; NEURAL STEM CELL; OLFACTORY BULB; PHYSIOLOGY; RAT; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TRANSPLANTATION; WISTAR RAT;

ADIPOCYTES; ALBUMINS; ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE REGENERATION; NEURAL STEM CELLS; NEUROGLIA; OLFACTORY BULB; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

ANIMALIA; RATTUS;

EID: 84872181439     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Arboleda D., Forostyak S., Jendelova P., Marekova D., Amemori T., Pivonkova H., Masinova K. and Sykova E. (2011). Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury. Cell Mol. Neurobiol. 31, 1113-1122.
2. Balentine J.D. (1978). Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab. Invest. 39, 254-266.
3. Barnett S.C. and Riddell J.S. (2004). Olfactory Ensheathing Cells (OECs) and the treatment of CNS injury: advantages and possible caveats. J. Anat. 204, 57-67.
4. Basso D.M., Beattie M.S. and Bresnahan J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
5. Brazda N. and Müller H.W. (2009). Pharmacological modification of the extracellular matrix to promote regeneration of the injured brain and spinal cord. Prog. Brain Res. 175, 269-281.
6. Busch S.A. and Silver J. (2007). The role of extracellular matrix in CNS regeneration. Curr. Opin. Nerurobiol. 17, 120-127.
7. Cadelli D.S., Bandtlow C.E. and Schwab M.E. (1992). Oligodendrocyte and myelinassociated inhibitors of neurite outgrowth: their involvement in the lack of CNS regeneration. Exp. Neurol. 115, 189-192.
8. Ceccatelli S., Tamm C., Sleeper E. and Orrenius S. (2004). Neural stem cells and cell death. Toxicol. Lett. 149, 59-66.
9. Chopp M. and Li Y. (2002). Treatment of neural injury with marrow stromal cells. Lancet Neurol. 1, 92-100.
10. Collazos-Castro J.E., Muñeton-Gomez V.C. and Nieto-Sampedro M. (2005). Olfactory glia transplantation into cervical spinal cord contusion injuries. J. Neurosurg. Spine 3, 308-317.
11. Demjen D., Klussmann S., Kleber S., Zuliani C., Stieltjes B., Metzger C., Hirt U.A., Walczak H., Falk W., Essig M., Edler L., Krammer P.H., Martin-Villalba A. (2004). Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat. Med. 10, 389-395.
12. Deng Y.B., Liu X.G., Liu Z.G., Liu X.L., Liu Y. and Zhou G.Q. (2006). Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy 8, 210-214.
13. Deng Y.B., Liu Y., Zhu W.B., Bi X.B., Wang Y.Z., Ye M.H. and Zhou G.Q. (2008). The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy 10, 551-564.
14. Fawcett J.W. and Asher R.A. (1999). The glial scar and central nervous system repair. Brain Res. Bull. 49, 377-391.
15. Gallego L., Junquera L., Meana A., Alvarez-Viejo M. and Fresno M. (2009). Ectopic bone formation from mandibular osteoblasts cultured in a novel human serum-derived albumin scaffold. J. Biomater. Appl. 25, 367-381.
16. Gallego L., Junquera L., Garcia E., Garcia V., Alvarez-Viejo M., Costilla S., Fresno M.F. and Meana A. (2010). Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold. Tissue Eng. 16, 1179-1187.
17. Garcia-Alias G., Lopez-Vales R., Fores J., Navarro X. and Verdu E. (2004). Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat. J. Neurosci. Res. 75, 632-641.
18. Groves A.K., Barnett S.C., Franklin R.J., Crang A.J., Mayer M., Blakemore W.F. and Noble M. (1993). Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362, 453-455.
19. Gudiño-Cabera G. and Nieto-Sampedro M. (1996). Ensheathing cells: Large scale purification from adult olfactory bulb, freeze-preservation and migration of transplanted cells in adult brain. Rest. Neurol. Neurosci. 10, 25-34.
20. Jin K., Mao X.O., Batteur S., Sun Y. and Greenberg D.A. (2003). Induction of neuronal markers in bone marrow cells: differential effects of growth factors and patterns of intracellular expression. Exp. Neurol. 84, 78-89.
21. Johansson C.B., Momma S., Clarke D.L., Risling M., Lendahl U. and Frisen J. (1999). Identification of a neural stem cell in the adult mammalian central nervous system. Cell. 96, 25-34.
22. Kang S.K., Lee D.H., Bae Y.C., Kim H.K., Baik S.Y. and Jung J.S. (2003). Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp. Neurol. 183, 355-366.
23. Li C., Li L., Zhe-Yu C., Li-Mei W., Jun-Li Y., Hai-Yan Q., Chang-Lin L. and Cheng H. (2004). Olfactory ensheating cells genetically modified to secrete GDNF to promote spinal cord repair. Brain 127, 535-549.
24. Lu J., Feron F., Mackay-Sim A. and Waite P.M. (2002). Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain 125, 14-21.
25. Madigan N.N., McMahon S., O'Brien T., Yaszemski M.J. and Windebank A.J. (2009). Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir. Physiol. Neurobiol. 169, 183-199.
26. McDonald J.W. and Becker D. (2003). Spinal cord injury: promising interventions and realistic goals. Am. J. Phys. Med. Rehabil. 82, S38-49.
27. McGee A.W. and Strittmatter S.M. (2003). The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci. 26, 193-198.
28. Meana A., Garcia E., Garcia V., Jorcano J.L., del Rio M., Larcher F., Duarte B. and Holguin A. (2008). Method for preparing threedimensional structures for tissue engineering. WO/2008/119855.
29. Olson H.E., Rooney G.E., Gross L., Nesbitt J.J., Galvin K.E., Knight A., Chen B., Yaszemski M.J. and Windebank A.J. (2009). Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng. Part A. 15, 1797-1805.
30. Radtke C., Aizer A.A., Agulian S.K., Lankford K.L., Vogt P.M. and Kocsis J.D. (2009). Transplantation of olfactory ensheathing cells enhances peripheral nerve regeneration after microsurgical nerve repair. Brain Res. 1254, 10-17.
31. Raisman G. (1985). Specialized neuroglial arrangement nay explain the capacity of vomeronasal axons to reinnervate central neurons. Neuroscience. 14, 237-254.
32. Raisman G. (2001). Olfactory ensheathing cells-another miracle cure for spinal cord injury? Nat. Rev. Neurosci. 2, 369-375.
33. Ramon-Cueto A. and Nieto-Sampedro M. (1994). Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp. Neurol. 127, 232-244.
34. Ramon-Cueto A., Plant G.W., Avila J. and Bunge M.B. (1998). Longdistance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J. Neurosci. 18, 3803-3815.
35. Ramon-Cueto A., Cordero M.I., Santos-Benito F.F. and Avila J. (2000). Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25, 425-435.
36. Resnick D.K., Cechvala C.F., Yan Y., Witwer B.P., Sun D. and Zhang S. (2003). Adult olfactory ensheating cell transplantation for acute spinal cord injury. J. Neurotrauma 20, 279-285.
37. Schwab M.E. and Caroni P. (2008). Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 60, 404-405.
38. Straley K.S., Foo C.W. and Heilshorn S.C. (2010). Biomaterial design strategies for the treatment of spinal cord injuries. J. Neurotrauma 27, 1-19.
39. Tatard V.M., D'Ippolito G., Diabira S., Valeyev A., Hackman J., McCarthy M., Bouckenooghe T., Menei P., Montero-Menei C.N. and Schiller P.C. (2007). Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone 40, 360-373.
40. Vaquero J., Zurita M., Oya S. and Santos M. (2006). Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neurosci. Lett. 398,129-134.
41. Verdu E., Garcia-Alias G., Fores J., Gudiño-Cabrera G., Muñeton V.C., Nieto-Sampedro M. and Navarro X. (2001). Effects of ensheating cells transplanted into photochemically damaged spinal cord. Neuroreport 12, 2303-2309.
42. Verdu E., Garcia-Alias G., Fores J., Lopez-Vales R. and Navarro X. (2003). Olfactory ensheathing cells transplanted in lesioned spinal cord prevent loss of spinal cord parenchyma and promote functional recovery. Glia 42, 275-286.
43. Wang B., Zhao Y., Lin H., Chen B., Zhang J., Zhang J., Wang X., Zhao W. and Dai J. (2006). Phenotypical analysis of adult rat olfactory ensheathing cells on 3-D collagen scaffolds. Neurosci. Lett. 401, 65-70.
44. Wang B., Han J., Gao Y., Xiao Z., Chen B., Wang X., Zhao W. and Dai J. (2007). The differentiation of rat adipose-derived stem cells into OEC-like cells on collagen scaffolds by co-culturing with OECs. Neurosci. Lett. 421, 191-196.
45. Yarak S. and Okamoto O.K. (2010). Human adipose-derived stem cells: current challenges and clinical perspectives. An. Bras. Dermatol. 85, 647-656.
46. Zeltinger J., Sherwood J.K., Graham D.A., Müeller R. and Griffith L.G. (2001). Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 7, 557-572.
47. Zhang L., Ma Z., Smith G.M., Wen X., Pressman Y., Wood P.M. and Xu X.M. (2009). GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia 57, 1178-1191.
48. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P. and Hedrick M.H. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7, 211-228.
49. Zurita M. and Vaquero J. (2006). Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation. Neurosci. Lett. 402, 51-56.
50. Zurita M., Vaquero J., Bonilla C., Santos M., de Haro J., Oya S. and Aguado C. (2008). Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Transplantation 86, 845-853.